Page last updated: 2024-08-25

efaroxan and repaglinide

efaroxan has been researched along with repaglinide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berggren, PO; Zaitsev, SV; Zaitseva, II1

Other Studies

1 other study(ies) available for efaroxan and repaglinide

ArticleYear
Insulinotropic compounds decrease endothelial cell survival.
    Toxicology in vitro : an international journal published in association with BIBRA, 2016, Volume: 33

    Topics: Benzofurans; Carbamates; Cell Proliferation; Cell Survival; Cells, Cultured; Dimethyl Sulfoxide; Glucose; Glyburide; Human Umbilical Vein Endothelial Cells; Humans; Hypoglycemic Agents; Imidazoles; Indoles; Nitric Oxide; Piperidines; Vascular Endothelial Growth Factor A

2016